IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,716,493 | -7.8% | 1,557,435 | +9.7% | 7.49% | -9.6% |
| Q2 2023 | $26,795,400 | +445.9% | 1,420,000 | +11.1% | 8.29% | +309.1% |
| Q1 2023 | $4,908,288 | +54.8% | 1,278,200 | +99.9% | 2.03% | +123.4% |
| Q4 2022 | $3,170,774 | +51.2% | 639,269 | +45.7% | 0.91% | +27.9% |
| Q3 2022 | $2,097,000 | +11.9% | 438,695 | +5.3% | 0.71% | +22.9% |
| Q2 2022 | $1,874,000 | -58.3% | 416,479 | -55.9% | 0.58% | -69.0% |
| Q1 2022 | $4,498,000 | -60.0% | 945,000 | -37.6% | 1.86% | -59.1% |
| Q4 2021 | $11,237,000 | +204.9% | 1,514,411 | +133.0% | 4.55% | +118.6% |
| Q3 2021 | $3,685,000 | -32.4% | 649,919 | -21.5% | 2.08% | -14.4% |
| Q2 2021 | $5,454,000 | -7.7% | 827,587 | +13.5% | 2.43% | -24.5% |
| Q1 2021 | $5,908,000 | +52.7% | 729,364 | +21.6% | 3.22% | +43.4% |
| Q4 2020 | $3,870,000 | – | 600,000 | – | 2.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| Northeast Financial Consultants Inc | 34,315 | $133,000 | 0.06% |